The US Food and Drug Administration ( FDA ) has given the go - ahead for an implantable glucose - monitoring device that can remain in the body for up to 90 days . Implanted and later removed by a health professional , the Eversense continuous glucose - monitoring ( CGM ) system sits under the skin and monitors the body ’s glucose levels , sending data to a free mobile app every five minutes . Comparable external sensors will typically need replacing after just 10 days .
The US Food and Drug Administration (FDA) has given the go-ahead for an implantable glucose-monitoring device that can remain in the body for up to 90 days. Implanted and later removed by a health professional, the Eversense continuous glucose-monitoring (CGM) system sits under the skin and detects the body’s glucose levels, sending data to a paired mobile app every five minutes. Comparable external sensors will typically need replacing after just 10 days.